Orthofix Wins 510(k) Clearance for G-Beam Fusion Beaming System

The FDA gave Orthofix’s G-Beam fusion beaming system clearance for the treatment of the debilitating condition Charcot foot where bones in the foot weaken and collapse.

The G-Beam devices can be implanted in the affected foot’s medial and lateral columns to give alignment, stabilization and fixation.

When internal fixation is recommended, the system is designed to fuse the medial and/or lateral columns, in addition to bones in the hindfoot, to restore a stable foot that may reduce the probability of amputation.